Related Topics
Take Another Quiz

Tpn-iv Quiz

21 Questions
Nutrition Quizzes & Trivia
Questions and Answers
  • 1. 
    • A. 

      Achieve catabolism

    • B. 

      Generate formation of ketone bodies

    • C. 

      Achieve anabolism

    • D. 

      Create necessary branched chain amino acids to stimulate hyperosmolar syndrome

  • 2. 
    • A. 

      Hypodermoclysis, hyperalimentation, or hyperal

    • B. 

      Intravenous hyperalimentation (IVH), hyperal, or hypodermoclysis

    • C. 

      Hyperalimentation, hypodermoclysis, or intravenous hyperalimentation

    • D. 

      Hyperal, hyperalimentation, or intravenous hyperalimentation

  • 3. 
    Which of the following are common indicators for TPN therapy?
    • A. 

      Coma, citrate toxicity, and bowel surgery

    • B. 

      Renal failure, prolonged ileus, and gastrocutaneous fistulas

    • C. 

      Hepatic failure, hypermetabolic states, and malabsorption of enteral therapy

    • D. 

      Filtration, multiple trauma, and conditions requiring bowel rest

  • 4. 
    What is the most common carbohydrate used for TPN?
    • A. 

      Dextrose

    • B. 

      Fructose

    • C. 

      Invert sugar

    • D. 

      Lactose

  • 5. 
    What is the source of protein used in TPN?
    • A. 

      Alpha globulins

    • B. 

      Casein amino acids

    • C. 

      Free amino acids

    • D. 

      Immunoglobulins

  • 6. 
    What substances are generally added to total parenteral nutrition solutions?
    • A. 

      Electrolytes, trace elements, and vitamins

    • B. 

      Antifungal agents, electrolytes, and vitamins

    • C. 

      Electrolytes, antihistamine antagonists, and vitamins

    • D. 

      Citrate preservative, electrolytes, and vitamins

  • 7. 
    Which of the following is indicated to treat essential fatty acid deficiency?
    • A. 

      50% dextrose

    • B. 

      Branched chain amino acids

    • C. 

      Lipids

    • D. 

      Selenium

  • 8. 
    • A. 

      Lipids, dextrose, and amino acids

    • B. 

      Lipids, heparin, and electrolytes

    • C. 

      Lipids, vitamins, and trace elements

    • D. 

      Lipids, electrolytes, and amino acids

  • 9. 
    • A. 

      Designed for acutely stressed patients

    • B. 

      Used for therapies of 6 to 12 weeks

    • C. 

      Crystalline amino acids used are within the 2-5% range

    • D. 

      Standard dextrose concentration is usually 20%

  • 10. 
    • A. 

      It is useful for long-term therapy

    • B. 

      It is indicated for patients with low calorie and nutrient needs

    • C. 

      The 1800-2000 mOsm/kg concentration range frequently causes phlebitis

    • D. 

      Lipid administration is done only IVPB

  • 11. 
    The regimen of time for the delivery of cyclic TPN therapy is usually how many hours?
    • A. 

      2-4

    • B. 

      6-10

    • C. 

      8-12

    • D. 

      12-18

  • 12. 
    • A. 

      They may be infused by gravity flow

    • B. 

      Flow rate adjustments are necessary to compensate for past increases or decreases

    • C. 

      Initial infusions should begin slowly with incremental increases until desired infusion rate is achieved.

    • D. 

      Weaning is not required when therapy is discontinued

  • 13. 
    Potential TPN-associated metabolic complications include which of the following?
    • A. 

      Sepsis, glucose intolerance, and electrolyte imbalances

    • B. 

      Cachexia, glucose intolerance, and essential fatty acid deficiency

    • C. 

      Lipoid nephrosis, glucose intolerance, and electrolyte imbalances

    • D. 

      Glucose intolerance, electrolyte imbalances, and essential fatty acid deficiency

  • 14. 
    The reversal of a hyperglycemic, hyperosmolar, nonketonic coma secondary to TPN requires the administration of:
    • A. 

      Anticoagulants

    • B. 

      Histamine blockers

    • C. 

      Insulin

    • D. 

      Sodium lactate

  • 15. 
    Dry-scaling skin, thinning hair, thrombocytopenia, and liver function abnormalities are clinical manifestations of what condition?
    • A. 

      Essential fatty acid deficiency

    • B. 

      Hyperlipemia

    • C. 

      Hyperosmolar syndrome

    • D. 

      Hypoglycemia

  • 16. 
    What is the primary cause of TPN-related sepsis?
    • A. 

      Fibrin sheath formation

    • B. 

      Intrinsic contamination of nutrient solution

    • C. 

      Migration of microorganisms along the catheter

    • D. 

      Seeding from other infection source in the body

  • 17. 
    Which of the following filter porosity ratings is appropriate for use with three-in-one nutrient solutions?
    • A. 

      0.22u

    • B. 

      1.2u

    • C. 

      2.5u

    • D. 

      5u

  • 18. 
    The administration set used for the infusion of TPN solutions should be changed according to what schedule?
    • A. 

      With each container of fluid

    • B. 

      Every 24 hours

    • C. 

      Every 48 hours

    • D. 

      Every 72 hours

  • 19. 
    • A. 

      Monitoring lipemia clearance on a weekly basis

    • B. 

      Using only central venous access for the infusion

    • C. 

      Testing urine for glycosuria every 6 hours

    • D. 

      Using non-PVC tubing

  • 20. 
    Lipid therapy is contraindicated when which of the following conditions are present?
    • A. 

      Cancer cachexia and pathologic hyperlipemia

    • B. 

      Lipoid nephrosis and lipatrophia

    • C. 

      Pathologic hyperlipemia and lipoid nephrosis

    • D. 

      Thrombocytopenia and lipoid nephrosis

  • 21. 
    • A. 

      In the central supply department

    • B. 

      Under a laminar flow hood in the pharmacy

    • C. 

      In a clean medication room on the nursing division

    • D. 

      At the patient's bedside

Related Topics